Alfonso Illiano

Author PubWeight™ 31.91^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.	Lancet Oncol	2012	22.04
2	Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.	Lancet Oncol	2005	2.36
3	Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.	J Clin Oncol	2005	2.11
4	Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.	J Clin Oncol	2003	2.09
5	EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.	Cancer Cytopathol	2013	1.62
6	Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.	J Clin Oncol	2007	0.99
7	EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study.	J Clin Pathol	2011	0.91
8	Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.	Lung Cancer	2012	0.83
9	EGFR mutations detection on liquid-based cytology: is microscopy still necessary?	J Clin Pathol	2012	0.77
10	Optimizing response to gefitinib in the treatment of non-small-cell lung cancer.	Pharmgenomics Pers Med	2011	0.75